Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
(marketscreener.com) CHARLOTTESVILLE, Va., May 08, 2024 -- Acumen Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s di...